Early Minimally Invasive Image Guided Endoscopic Evacuation of Intracerebral Haemorrhage (EMINENT-ICH)
Key facts
- Who runs it
- University Hospital, Basel, Switzerland
- Where
- Switzerland10 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 1 Jan 2024
- Expected to end
- Dec 2029
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Early minimally invasive image guided endoscopic hematoma evacuation
- Best medical treatment (BMT)
- Record updated
- 22 July 2024
Who can take part
- Age
- 18 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Spontaneous supratentorial intracerebral hemorrhage (SSICH), defined as the sudden occurrence of bleeding into the lobar parenchyma and/or into the basal ganglia and/or thalamus that may extend into the ventricles confirmed by imaging
- SSICH volume ≥20 mL <100 mL
- A focal neurological deficit consisting of either; clinically relevant hemiparesis (≥4 motor points on the NIHSS for facial palsy, motoric upper and lower extremities combined); clinically relevant motor or sensory aphasia (≥2 points on the NIHSS); clinically relevant hemi-inattention (formerly neglect, 2 points on the NIHSS); decreased level of consciousness (Glasgow Coma Scale (GCS)≤13)
- Presenting GCS 5 - 15 (in intubated patients GCS assessment will be performed after Rutledge et al. or if impossible, the last pre-intubation GCS will be used)
- Endoscopic hematoma evacuation can be initiated within 24 hours after the patient was last seen well/symptom onset
- Informed consent of patient or appropriate surrogate (for patients without competence)
Who cannot take part
- Relevant disability prior to SSICH (mRS >2)
- Infratentorial hemorrhage or midbrain extension/involvement of the hemorrhage
- Any comorbid disease or condition expected to compromise survival or ability to complete follow-up assessments through 180 days (e.g. bilateral fixed dilated pupils)
- Coagulation disorder (including anticoagulation) with an international normalized ratio (INR) of >1.5 which cannot be pharmacologically reverted until the planned time of evacuation
- SSICH due to known or suspected structural abnormality in the brain (e.g. vascular malformation, aneurysm, arteriovenous malformation (AVM), brain tumor) and/or brain trauma and/or hemorrhagic conversion of an ischemic infarction
- Multiple simultaneous intracranial hemorrhages (ICH) (e.g. multifocal ICH, chronic subdural hematoma (cSDH), acute subdural hematoma (aSDH), SAH)
- Pregnancy
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is an open-labelled, single centre randomised controlled trial evaluating the efficacy of early minimally invasive image-guided hematoma evacuation in combination with the current best medical treatment compared to best medical treatment alone in improving functional outcome rates at 6 months after initial treatment in patients with spontaneous supratentorial intracerebral haemorrhage.
The 2 groups in the trial
- Study InterventionTreatment being tested
Early minimally invasive image guided endoscopic hematoma evacuation as an add-on therapy to BMT performed within 24 hours after SSICH symptom onset.
Treatment: Early minimally invasive image guided endoscopic hematoma evacuation and Best medical treatment (BMT)
- Control InterventionExisting treatment, for comparison
Best medical treatment i.e. active blood pressure control, seizure prophylaxis and care as according to the current guidelines.
Treatment: Best medical treatment (BMT)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Early Minimally Invasive Image Guided Endoscopic Evacuation of Intracerebral Haemorrhage (EMINENT-ICH): a Randomized Controlled Trial
- Fit questions
- Built from NCT05681988, who can take part
- Publications
- Early minimally invasive image-guided eNdoscopic evacuation of iNTracerebral hemorrhage: a phase II pilot trial.Frontiers in neurology, 2024
- Early minimally invasive image-guided endoscopic evacuation of intracerebral hemorrhage (EMINENT-ICH): a randomized controlled trial.Trials, 2024
- Treatment for intracerebral hemorrhage: Dawn of a new era.International journal of stroke : official journal of the International Stroke Society, 2024
- Record updated
- 22 July 2024